
TSE:BNS
This summary was created by AI, based on 30 opinions in the last 12 months.
The Bank of Nova Scotia (BNS) has received mixed reviews from experts, highlighting its strong dividend yield and international focus, particularly in Latin America. While many analysts appreciate its valuation being relatively low compared to peers, there are concerns about strategic direction due to its recent investments. The bank is viewed positively for its turnaround potential under new management, yet some analysts caution about potential credit issues and the broader economic landscape affecting its performance. Overall, experts express a sense of cautious optimism, suggesting it is a solid long-term hold but emphasizing the importance of timing for new purchases.
This is part of his Canadian portfolio. From the point of view of Canadian holdings, this is a good company to own because they’ve made two good acquisitions on the wealth management side. These will be accretive. Also the market seems to be successfully absorbing higher interest rates. Over the longer term, this has been a solid performer and it offers a good dividend yield. That makes it an interesting story even from the global perspective. (Analysts’ price target is $86.29)
They've been punished more than their peers. They just acquired some top money managers and the street punished them. There'll be a write-off this quarter, but long-term these additions will benefit BNS. Pays a great dividend and should be enough growth to perform well. Well-managed. (Analysts' price target: $86.40)
(Past Top Pick, June 7, 2017, Up 4%) They're exposed to South America which are tied to commodities. So if there are commodity worries, then it effects this stock. He believes in management's investments in technology and that their Latin American presence will pay off in the long run. It remains a major holding for him and he will stick with it. It's a good buy here.
The stock is close to its 52-week low, dragged down by 2 factors: (a) It is the most international bank and EM markets have struggled this year. A strong US dollar hurts emerging markets. (b) They have done acquisitions and issued shares in the process. He owns this stock despite its price pressure. “You don’t ever go really wrong by buying the Canadian banks.” They are an oligopoly, they have great management teams and they always tend to recover. This is a trading opportunity: good value, good volatility, but weak price momentum at this time.
This is the only Canadian bank they own. This is the most international bank in Canada, with more assets being owned outside of the country. These assets are not in the US. It has been hitting recent lows. When it sold its CI holdings, getting out of mutual funds, they have been buying a large asset manager and a private client business focusing on physician investors. The problem is the market feels they may have overpaid for these investments. Yield 4.4%. (Analysts’ price target is $86.40)
(A top pick October 18/17, down 1%) This one is still in the starting gate. This is the heaviest weighted bank in their portfolio. Scotiabank is the poster child for emerging market exposure with operations in Mexico, Latin America, and South America. They are getting bigger in those geographies. And have double downed on wealth management with the acquisition of MD Management. Sentiment changing in emerging markets should put it back on track.